ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,174, issued on April 22, was assigned to Inspirna Inc. (New York).
"High-affinity anti-MERTK antibodies and uses thereof" was invented by Masoud Tavazoie (New York), Isabel Kurth (New York), Shugaku Takeda (Queens Village, N.Y.), Celia Andreu-Agullo (New York) and Ivo Lorenz (Brooklyn, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies (e.g., humanized antibodies) that specifically bind to Mer Tyrosine Kinase (MERTK; e.g., human MERTK) and compositions comprising such antibodies. The present disclosure also provides antibody-drug conjugates comprising (i) an anti-MERTK antibody or antigen-binding fragment t...